Charles River Laboratories

Charles River Laboratories is a leading Contract Research Organization (CRO) dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies in developing life-saving medicines and therapies.

Charles River Laboratories is a global Contract Research Organization (CRO) committed to "creating healthier lives." They provide critical research support to pharmaceutical, biotechnology, and medical device companies worldwide, collaborating with universities, research institutions, and government organizations. With decades of experience, Charles River offers a comprehensive portfolio of services, including research models, drug discovery and development support, safety assessment, and biologics testing. Their expertise helps clients expedite preclinical drug development, ensure product safety and quality, and bring novel therapies to market. As a leader in research models, they supply high-quality research animals and specialized models for basic research and discovery. Their integrated portfolio, backed by hundreds of scientists, employs advanced technology for chemistry, biology, and pharmacology services, supporting clients from early hit identification through investigational new drug (IND) applications. They also offer robust safety assessment services and regulatory guidance, conducting approximately 120 IND programs annually. Furthermore, Charles River provides extensive endotoxin testing, microbial detection, and identification solutions designed to meet industry needs and regulatory requirements. Their Biologics group, with over 50 years of experience, offers a wide range of services to address complex projects for biotechnology and pharmaceutical companies, supporting over 20,000 biologic testing reports and 200 licensed products each year.

About

**Who they are**
Charles River Laboratories is a leading Contract Research Organization (CRO) dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies. They focus on developing life-saving medicines and therapies.

**Expertise & scope**
* Support for pharmaceutical, biotechnology, and medical device companies.
* Focus on the development of medicines and therapies.

**Reputation / proof points**
* Founded in 1947 (implied by company history, not explicitly stated as a proof point for this specific service).

Additional information

Charles River Laboratories operates as a Contract Research Organization (CRO), offering a broad spectrum of services to support the development of new medicines and therapies. Their client base includes pharmaceutical, biotechnology, and medical device companies. The organization's primary mission is to advance global health through scientific innovation and dedicated support in drug discovery and development processes.

Key Highlights

  • Leading Contract Research Organization (CRO) supporting life sciences. Source
    “Charles River Laboratories is a leading Contract Research Organization (CRO) dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies in developing life-saving medicines and therapies.”

Certifications & Trust Signals

  • Dedicated to improving global health. Source
    “dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies”

Buyer Snapshot

Best for
  • Pharmaceutical companies
  • Biotechnology companies
  • Medical device companies
How engagement typically works
  • Contract research support
  • Development partnerships
Typical deliverables
  • Support for drug development
  • Therapeutic innovation
Good to know
  • Best when seeking comprehensive CRO services for life-saving medicine development.
HQ: US
Languages: English
Claim status: Listed

Services & Capabilities

Biocompatibility Testing (ISO 10993 Program)

Industries: Medical Devices
Pricing model: Custom pricing
Iso10993 Standards Supported: ISO 10993-1, ISO 10993-5, ISO 10993-10, ISO 10993-11
Test Types Offered: Cytotoxicity, Sensitization, Irritation, Systemic toxicity, Genotoxicity, Implantation, Hemocompatibility, Pyrogenicity, Biodegradation
Glp Compliant: Yes
Has In House Toxicology: Yes
Toxicology Capabilities: Comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to investigational new drugs (IND). Expedite their preclinical drug development with exceptional, comprehensive safety assessment services, state-of-the-art facilities, and expert regulatory guidance. Approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities each year. Provide a comprehensive portfolio of endotoxin testing, microbial detection, and microbial identification products and services. Biologics group provides a breadth of services that can address challenging projects for biotechnology and pharmaceutical companies worldwide.
Contact Types Supported: Surface contact, External communicating, Implant
Duration Types Supported: Limited (< 24h), Prolonged (24h - 30d), Permanent (> 30d)
Nda Support: Yes
Lead Time Band: Start in 4-8 weeks
Quote SLA: 3-5 business days
Sample Return Policy: Both options
Minimum Project Size: $50k+

Additional biocompatibility_testing Details

Iso10993 Standards Supported
ISO 10993
Test Types Offered
Biocompatibility testing
Lead Time Band
Start in 4-8 weeks
Quote SLA
3-5 business days
Sample Return Policy
Dispose
Minimum Project Size
$50k+
Pricing Model
Custom
Request quotes
Cruxi - Regulatory Compliance Services